Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment

NCT01820910 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Marginal Zone Lymphoma of Ocular Adnexal

Interventions

DRUG: Doxycycline

Sponsor

International Extranodal Lymphoma Study Group (IELSG)